Close Menu

NEW YORK (360Dx) – MdxHealth announced today that it has entered into an agency service agreement with Unilabs for MDxHealth's SelectMDx urine test for prostate cancer.

Under the terms of the agreement, Unilabs will offer SelectMDx to patients of all its clinical labs in France, Portugal, Sweden, Norway, Denmark, Finland, UK, Italy, and Switzerland. Unilabs' medical laboratory in Geneva will perform the SelectMDx service testing. To offer the service throughout its network, Unilabs will purchase SelecMDx CE-market IVD kits from MDxHealth.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Thermo Fisher Scientific

With COVID-19 vaccines rolling out, clinical labs and test developers are preparing for changes in both demand for testing and types of testing for SARS-CoV-2.

Sponsored by

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

Sponsored by

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. 

Sponsored by

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.